| Salmon Pharma GmbH - Vafseo 150 mg, Filmtabletten | | 68862 | | 01 | | Vafseo 150 mg | | Filmtabletten | | B03XA08 | | | | 19.06.2023 | | |
| | Composition | | vadadustatum 150 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 0.38 - 0.58 mg. | | Packungsbestandteile | | Coated tablets | | | | | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | color. | | Hypromellosum | | | | Macrogol | 3350 | | | | | | | | | Überzug | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 | PR | PR | A | | No | | 002 | 98 | PR | PR | A | | No |
|
|
